RENALYTIX PLC

Active London

Other professional, scientific and technical activities n.e.c.

44 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
R

RENALYTIX PLC

Other professional, scientific and technical activities n.e.c.

Founded 15 Mar 2018 Active London, United Kingdom 44 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.

Previous Company Names

RENALYTIX AI PLC 15 Mar 2018 — 23 Jun 2021
Accounts Submitted 31 Dec 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 22 Mar 2026 Next due 23 Mar 2027 11 months remaining
Net assets £-5M £1M 2025 year on year
Total assets £4M £2M 2025 year on year
Total Liabilities £10M £3M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

2 Leman Street London E1W 9US United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for RENALYTIX PLC (11257655), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 15 Mar 2018. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Balance Sheet & P&L (2019–2025)

Cash in Bank

£2.62M

Decreased by £1.07M (-29%)

Net Assets

-£5.10M

Increased by £1.10M (+18%)

Total Liabilities

£9.55M

Decreased by £2.96M (-24%)

Turnover

£2.19M

Increased by £180.71k (+9%)

Employees

44

Debt Ratio

215%

Increased by 16 (+8%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

30 Allotments 399,255,588 Shares £949013799.37m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
15 Oct 202531,650,034£3.01m£0.095
29 Sept 202564,908,955£6.17m£0.095
26 Sept 20259,253,679£879k£0.095
1 Nov 2024141,272,726£12.71m£0.09
9 Oct 202424,007,773£2.16m£0.09

Officers

Officers

1 active 2 resigned
Status
Salim Gulamabbas HamirSecretaryUnknownUnknown15 Mar 2018Active

Shareholders

Shareholders (16)

Icahn School Of Medicine At Mount Sinai, Inc.
11.3%
Cvi Investments, Inc.
10.0%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased
Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Mar 2026Confirmation StatementConfirmation statement made on 2026-03-09 with no updates
19 Mar 2026OfficersChange to director James Mccullough on 2021-05-01
19 Mar 2026OfficersChange to director Fergus Fleming on 2018-11-01
19 Mar 2026OfficersChange to director Dr Erik Kristian Lium on 2025-09-01
2 Jan 2026OfficersAppointment of One Advisory Limited as director on 2026-01-01
22 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-03-09 with no updates

19 Mar 2026 Officers

Change to director James Mccullough on 2021-05-01

19 Mar 2026 Officers

Change to director Fergus Fleming on 2018-11-01

19 Mar 2026 Officers

Change to director Dr Erik Kristian Lium on 2025-09-01

2 Jan 2026 Officers

Appointment of One Advisory Limited as director on 2026-01-01

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-09 with no updates

4 weeks ago on 22 Mar 2026

Change to director James Mccullough on 2021-05-01

1 months ago on 19 Mar 2026

Change to director Fergus Fleming on 2018-11-01

1 months ago on 19 Mar 2026

Change to director Dr Erik Kristian Lium on 2025-09-01

1 months ago on 19 Mar 2026

Appointment of One Advisory Limited as director on 2026-01-01

3 months ago on 2 Jan 2026